**Question:** Isoprostanes are formed from arachidonic acid by -

A. Cyclooxygenase pathway
B. Lipoxygenase pathway
C. Cytochrome P450 pathway
D. Phospholipase pathway

**Core Concept:**
Arachidonic acid is an omega-6 polyunsaturated fatty acid that serves as a precursor for the synthesis of eicosanoids, including prostaglandins, thromboxanes, and leukotrienes. Isoprostanes are a group of prostaglandin-like compounds that are formed non-enzymatically from arachidonic acid under oxidative stress conditions, especially in the presence of reactive oxygen species (ROS).

**Why the Correct Answer is Right:**
Isoprostanes are formed through a non-enzymatic mechanism involving the oxidative degradation of arachidonic acid by reactive oxygen species (ROS), especially in the context of cellular oxidative stress. They are not produced through the classical prostaglandin H synthase (COX) pathway, which involves enzymatic reactions catalyzed by cyclooxygenase (COX) enzymes.

**Why Each Wrong Option is Incorrect:**

A. Cyclooxygenase pathway (COX): This pathway involves enzymatic reactions catalyzed by cyclooxygenase (COX) enzymes, leading to the formation of prostaglandins, thromboxanes, and prostacyclins. Since isoprostanes are formed non-enzymatically, this pathway is incorrect.

B. Lipoxygenase pathway: This pathway involves the enzymatic conversion of arachidonic acid into leukotrienes and lipoxins. Similar to the cyclooxygenase pathway, the lipoxygenase pathway is enzymatic and not involved in isoprostane formation.

C. Cytochrome P450 pathway: The cytochrome P450 pathway is primarily associated with the synthesis of epoxygenase products and does not involve the formation of isoprostanes, which are non-enzymatic products derived from arachidonic acid oxidation.

D. Phospholipase pathway: Phospholipases are enzymes that break down phospholipids, not involved in the formation of isoprostanes. This pathway is incorrect in the context of isoprostane synthesis.

**Clinical Pearls:**
Isoprostanes are considered biomarkers of oxidative stress and are often used to assess oxidative damage in various diseases, including cardiovascular diseases, neurodegenerative disorders, and inflammation-related conditions. Monitoring isoprostane levels can help diagnose and evaluate the severity of oxidative stress-related illnesses and guide therapeutic interventions.